Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cascade screening for familial hypercholesterolemia: Practical consequences.

Atherosclerosis. Supplements - 1 Nov 2017

Louter Leonora, Defesche Joep, Roeters van Lennep Jeanine

Abstract excerpt

Familial Hypercholesterolemia (FH) is an autosomal dominant disorder mainly caused by mutations in the LDLR gene, resulting in elevated serum cholesterol levels and elevated risk of premature cardiovascular disease (CVD). Timely treatment with lipid lowering medication can lower the risk of CVD to the same level of the normal population. Currently the incidence of FH is estimated at 1 in 240 persons in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, LDL
Share to Cooperative Behavior
Share to Hyperlipoproteinemia Type II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to International Cooperation

Share to Lipid Metabolism

Share to Netherlands

Share to Predictive Value of Tests

Share to Registries

Source

Identifiers

PMID: 29096865
DOI: 10.1016/j.atherosclerosissup.2017.05.019

Genes

LDLR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cascade screening for familial hypercholesterolemia: Practical consequences.PMID 29096865Read ↗

Cascade screening for familial hypercholesterolemia should be organized at a national level.Semantic proximity Read ↗

Screening and treatment of familial hypercholesterolemia - Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014).Semantic proximity Read ↗

Cascade genetic screening for familial hypercholesterolemiaSemantic proximity Read ↗

Familial Hypercholesterolemia: Cascade Screening in Children and Relatives of the Affected.Semantic proximity Read ↗

Cascade screening of familial hypercholesterolemia must go on.Semantic proximity Read ↗

Cascade screening amplifies familial hypercholesterolaemia detection after clinically guided next- generation sequencingSemantic proximity Read ↗

Feasibility and cost of FH cascade screening in Belgium (BEL-CASCADE) including a novel rapid rule-out strategy.Semantic proximity Read ↗

Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China.Semantic proximity Read ↗

The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway.Semantic proximity Read ↗

[Familial hypercholesterolemia in the Czech Republic in 2016].Semantic proximity Read ↗

[Digiphysical cascade screening model to diagnose familial hypercholesterolemia in relatives to an index case].Semantic proximity Read ↗

Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.